Form 8-K - Current report:
SEC Accession No. 0001140361-23-011200
Filing Date
2023-03-10
Accepted
2023-03-10 16:50:21
Documents
12
Period of Report
2023-03-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10049580_8k.htm   iXBRL 8-K 46102
  Complete submission text file 0001140361-23-011200.txt   185017

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA adma-20230306.xsd EX-101.SCH 3880
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20230306_lab.xml EX-101.LAB 22546
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20230306_pre.xml EX-101.PRE 16054
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc10049580_8k_htm.xml XML 4239
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 23724405
SIC: 2836 Biological Products, (No Diagnostic Substances)